EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+6.24%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$7.83B
AUM Growth
+$7.83B
(+3.5%)
Cap. Flow
+$137M
Cap. Flow
% of AUM
1.76%
Top 10 Holdings %
Top 10 Hldgs %
24.31%
Holding
166
New
14
Increased
54
Reduced
26
Closed
20
Top Buys
| 1 |
dLocal
DLO
|
$139M |
| 2 |
Global E Online
GLBE
|
$105M |
| 3 |
Guardant Health
GH
|
$70.8M |
| 4 |
KNBE
KnowBe4, Inc. Class A Common Stock
KNBE
|
$66.2M |
| 5 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$42.7M |
Top Sells
| 1 |
Fiverr
FVRR
|
$127M |
| 2 |
Twilio
TWLO
|
$126M |
| 3 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
$91.8M |
| 4 |
Trade Desk
TTD
|
$52M |
| 5 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$38.4M |
Sector Composition
| 1 | Healthcare | 33.78% |
| 2 | Technology | 28.4% |
| 3 | Industrials | 14.84% |
| 4 | Consumer Discretionary | 8.57% |
| 5 | Communication Services | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Collegium Pharmaceutical
COLL
$1.25B
| $49.1M | 0.63% |
2,629,593
| – | – |
|
52
Xometry
XMTR
$2.37B
| $48.9M | 0.62% |
954,030
+211,228
| +28% | +$10.8M |
|
53
Verisk Analytics
VRSK
$37.5B
| $48.7M | 0.62% |
213,000
| – | – |
|
54
Celldex Therapeutics
CLDX
$1.57B
| $47.9M | 0.61% |
1,238,900
+110,900
| +10% | +$4.29M |
|
55
MongoDB
MDB
$25.5B
| $47.3M | 0.6% |
89,355
| – | – |
|
56
ESSA Pharma
EPIX
$11.2M
| $47.1M | 0.6% |
3,318,647
+1,137,546
| +52% | +$16.2M |
|
57
Zymeworks
ZYME
$1.07B
| $46.2M | 0.59% |
2,819,135
-910,054
| -24% | -$14.9M |
|
|
DICE
58
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $45.8M | 0.58% |
1,871,612
| – | – |
|
59
Shoals Technologies Group
SHLS
$1.13B
| $44.9M | 0.57% |
1,846,900
-58,160
| -3% | -$1.41M |
|
60
Zentalis Pharmaceuticals
ZNTL
$123M
| $44.5M | 0.57% |
529,000
| – | – |
|
61
Brookfield Renewable
BEP
$7B
| $44.2M | 0.57% |
1,236,000
| – | – |
|
|
MRTX
62
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $42.8M | 0.55% |
291,626
+162,155
| +125% | +$23.8M |
|
63
Coursera
COUR
$1.83B
| $42.5M | 0.54% |
1,738,228
+938,228
| +117% | +$22.9M |
|
|
BPMC
64
DELISTED
Blueprint Medicines
BPMC
| $42.4M | 0.54% |
395,800
+39,800
| +11% | +$4.26M |
|
65
Immunovant
IMVT
$2.91B
| $42.2M | 0.54% |
4,950,000
| – | – |
|
66
Monolithic Power Systems
MPWR
$39.6B
| $42M | 0.54% |
85,157
+7,698
| +10% | +$3.8M |
|
67
Sutro Biopharma
STRO
$85.6M
| $40.3M | 0.52% |
2,708,975
+338,000
| +14% | +$5.03M |
|
68
ADC Therapeutics
ADCT
$370M
| $39.9M | 0.51% |
1,975,000
+663,010
| +51% | +$13.4M |
|
|
CCXI
69
DELISTED
ChemoCentryx, Inc.
CCXI
| $37.9M | 0.48% |
1,040,000
| – | – |
|
70
nCino
NCNO
$3.55B
| $37.7M | 0.48% |
688,000
+25,500
| +4% | +$1.4M |
|
71
908 Devices
MASS
$199M
| $36.5M | 0.47% |
1,410,000
+727,729
| +107% | +$18.8M |
|
72
Lattice Semiconductor
LSCC
$9.16B
| $36.4M | 0.46% |
471,744
+413,297
| +707% | +$31.8M |
|
73
Annexon
ANNX
$225M
| $32.7M | 0.42% |
2,850,000
+318,372
| +13% | +$3.66M |
|
74
nVent Electric
NVT
$14.4B
| $31.6M | 0.4% |
832,200
+60,200
| +8% | +$2.29M |
|
75
Repligen
RGEN
$6.54B
| $31.5M | 0.4% |
119,000
| – | – |
|